Page last updated: 2024-10-29

iohexol and Ewing Sarcoma

iohexol has been researched along with Ewing Sarcoma in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhang, WD1
Zhao, LL1
Huang, XB1
Cai, PQ1
Xu, GX1

Other Studies

1 other study available for iohexol and Ewing Sarcoma

ArticleYear
Computed tomography imaging of anterior and middle mediastinal Ewing sarcoma/primitive neuroectodermal tumors.
    Journal of thoracic imaging, 2010, Volume: 25, Issue:2

    Topics: Adolescent; Adult; Biopsy, Needle; Bone Neoplasms; Contrast Media; Female; Humans; Iohexol; Male; Me

2010